Pathway enrichment analysis revealed that bladder cancer, the p53 signaling pathway, pancreatic cancer, endocrine resistance, cell cycle, non-small cell lung cancer, glioma, endometrial cancer, prostate cancer, and senescence pathway were closely related to the mechanism of LH20 (p < 0.05). Here, TP53 is linked to prostate carcinoma.